Acute exacerbations of COPD are a main cause of morbidity and mortality, and the biggest source of economic cost in patients with COPD. COPD exacerbations are very heterogeneous in severity, frequency and clinical presentation. This project aims to unravel clinical and genetic determinants for this heterogeneity in order to improve treatment of patients with COPD.